Global Transradial Access Devices Market : Industry Size, Share, Analysis, Trend & Future Planning 2022
Bharat Book Bureau Provides the Trending Market Research Report on“Global Transradial Access Devices Market, Forecast to 2022” underLife Sciences category. The report provides information on industry overview, market size, latest developments, industry trends,Top Players, global presence, and their future prospects.
Transradial Access Devices Market is estimated to grow at aCAGR of 7.5% during the forecast period
The global transradial access devices market is expected to grow at a CAGR of 7.5% to reach toUSD 2.18 billion by 2022 from an estimated USD 1.52 billion in 2017. The driving factors of this market are rising prevalence of obesity, increasing preference for interventional procedures using radial artery access, growing utilization of radial access devices in treating pediatric patients, and prevalence of lifestyle diseases.
Request a free sample copy ofTransradial Access Devices MarketReport @ https://www.bharatbook.com/request-sample/312856
The catheter segment is expected to grow at the highest rate during the forecast period
By product, the transradial access devices market is segmented into catheters, guidewires, sheaths and sheath introducers, and accessories (needles and cannulas). Catheters accounted for the largest share of the transradial access devices market in 2017 and this segment is also expected to grow at the highest rate during the forecast period. Factors driving the growth of this segment are the increasing incidence of lifestyle-related diseases such as CVD, obesity, and diabetes and the rising number of interventional and angiography procedures worldwide.
By applications, the drug administration segment is projected to be the highest growth rate in the next five years
Transradial access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. Of all these application segments, the drug administration segment commanded the largest share of the transradial access devices market in 2017.
The large share of this segment can be attributed to the high usage of vascular access devices for drug administration, predominantly for the treatment of cancer and infections.
The hospitals segment is expected to grow at the highest CAGR during the study period
On the basis of end users the transradial access devices market is categorized into hospitals, clinics and ambulatory care centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment is expected to grow at the highest CAGR during the forecast period.
North America is projected to grow at the highest CAGR during the forecast period
Transradial access devices market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to register the highest CAGR during the forecast period. The key driving factors for the growth of this regional segment are the growing prevalence of CVDs, increasing number of cancer patients and, increase in research and clinical trials for vascular access devices.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
- By Designation – C-level: 27%, Director Level: 15%, Others: 58%
- By Region – North America: 37%, Europe: 23%, Asia Pacific: 25%, RoW: 15%
Becton, Dickinson and Company (US) and Terumo Corporation (Japan) dominated the transradial access devices market.
To browse full research report with TOC, click the link below :
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on: Twitter, Facebook, LinkedIn, Google Plus